Review examines disrupted nighttime sleep in narcolepsy
A new literature review describes a consistent characterization of fragmented nighttime sleep in patients with narcolepsy.
18
09, 2013
Need a new search?
If you didn't find what you were looking for, try a new search!
25
07, 2013
FDA patient-focused narcolepsy meeting will be held Sept. 24
In April the Food and Drug Administration announced that narcolepsy was selected as one of the disease areas to be addressed during the first three years of its Patient-Focused Drug Development initiative. Last week the FDA announced that it will hold a public meeting to gather patient and patient stakeholder input on how narcolepsy impacts daily life and on current approaches to treating narcolepsy.
7
06, 2013
Narcolepsy study finds surprising increase in neurons that produce histamine
A new study provides surprising evidence that people with narcolepsy have an increased number of neurons that produce histamine, suggesting that histamine signaling may be a novel therapeutic target for this potentially disabling sleep disorder.
19
04, 2013
FDA selects narcolepsy as one disease area for patient-focused drug development
In a statement published in the Federal Register on April 11, the Food and Drug Administration announced that narcolepsy was selected as one of the disease areas to be addressed during the first three years of Patient-Focused Drug Development.
6
12, 2012
Discovery channel to air narcolepsy documentary Saturday
The program Narcolepsy: New Strategies for Diagnosis and Treatment will premier on Discovery Channel on Saturday, Dec. 8, at 7 a.m. (CST). The documentary follows the daily life of an individual with narcolepsy with cataplexy and features commentary from a group of AASM expert physicians. The documentary will air a second time on Saturday, Dec. 22, at 7 a.m. (CST).
31
08, 2009
Product Spotlight: Narcolepsy – Evaluation and Treatment, CD-ROM
One of six professional slide sets developed by the AASM Sleep Education Series; the Narcolepsy Slide Set was designed to serve as the foundation for a teaching curriculum on recognizing and treating narcolepsy.
31
07, 2008
Product Spotlight: Narcolepsy – Evaluation and Treatment, CD-ROM
The Narcolepsy slide set was designed to serve as the foundation for a teaching curriculum on recognizing and treating narcolepsy.
8
02, 2008
AASM Offers Narcolepsy Products for your Practice
The AASM offers an extensive line of professional sleep related products designed to help promote education on narcolepsy.
1
12, 2007
Practice Parameters Published in the Journal SLEEP Discuss Treatment for Narcolepsy and Other Hypersomnias of Central Origin
Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin.
1
10, 2007
Journal SLEEP: Lower Metabolism, Changes in Eating Behavior Possible Explanations for the Cause of Being Overweight with Narcolepsy
A lower metabolism, as well as slight changes in eating behavior, could explain the positive energy balance leading to being overweight with narcolepsy, according to a study published in the October 1 issue of the journal SLEEP.
1
08, 2007
Journal SLEEP: Persons with Narcolepsy with Cataplexy Have Low Levels of CSF Hypocretin-1, which Aids in the Regulation of Sleep
Persons with narcolepsy with cataplexy have low levels of cerebrospinal fluid (CSF) hypocretin-1, a protein thought to help regulate sleep and wakefulness, according to a study published in the August 1 issue of the journal SLEEP.
15
12, 2006
Journal SLEEP: Narcolepsy May Be Caused By Environmental Exposures
A comprehensive review published in the Jan. 1 issue of the journal SLEEP finds that, as with other diseases characterized by selective cell loss, narcolepsy may be caused by environmental exposures before the age of onset in genetically susceptible individuals.
12
10, 2006
New Study in the Journal SLEEP Shows That ICSD is a Reliable Guide to Classifying Narcolepsy
The International Classification of Sleep Disorders-2nd Edition (ICSD-2), a diagnostic and coding manual written and published by the American Academy of Sleep Medicine (AASM), is a proven effective method of classifying narcolepsy with cataplexy, according to a study published in the November 1st issue of the journal SLEEP.
10
04, 2026
Key trends in sleep medicine: Q1 2026
Recent developments across technology, therapeutics, policy, and public health point to several themes shaping the practice of sleep medicine in early 2026. Drawing on trends highlighted in the American Academy of Sleep Medicine’s State of Sleep Medicine Report for Q1 of 2026, this [...]
4
04, 2026
Sleep Medicine Weekly Insider – April 4, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. State of Sleep Medicine Report for Q1 The quarterly State of Sleep Medicine Report contains news highlights and [...]
3
04, 2026
State of Sleep Medicine Report | 2026, Q1
The State of Sleep Medicine Report is compiled quarterly by the American Academy of Sleep Medicine as a members only resource. The report contains news highlights and announcements to help members identify current trends and innovations in sleep medicine, recognize important developments in [...]
28
03, 2026
Sleep Medicine Weekly Insider – March 28, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. AASM announces 2026 award recipients Congratulations to the recipients of the 2026 AASM awards: Susan Redline, MD, MPH; Danny [...]
19
03, 2026
Obesity Management Resources
Obesity Management Resources The AASM Obesity Management Task Force compiled these resources to help equip sleep medicine professionals to manage obesity in patients who have sleep disorders. Obesity management options expanded in December 2024, when the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe [...]
14
03, 2026
Sleep Medicine Weekly Insider – March 14, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. APSS releases SLEEP 2026 schedule The Associated Professional Sleep Societies has posted the schedule announcement for SLEEP 2026, the 40th annual [...]
13
03, 2026
Case Study of the Month – March 2026
The AASM Case Study of the Month for March is about a 31-year-old married female, 28 weeks pregnant with her first child, when she presented with a history of narcolepsy diagnosed two years prior. The case was submitted by Debra J. Stultz, MD, [...]
7
03, 2026
Sleep Medicine Weekly Insider – March 7, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Cast your vote in leadership election AASM invites all eligible voting members to participate in the 2026 – 2027 leadership election. An email [...]
28
02, 2026
Sleep Medicine Weekly Insider – February 28, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Register for SLEEP 2026 postgraduate courses Enhance your expertise at SLEEP 2026! Postgraduate courses are now open. Explore cutting-edge [...]
21
02, 2026
Sleep Medicine Weekly Insider – February 21, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. FDA approves Wakix for cataplexy The FDA approved Harmony Biosciences’ supplemental new drug application for Wakix (pitolisant) tablets to [...]
20
02, 2026
Medication Mastery: Optimizing Treatment of the Central Disorders of Hypersomnolence
Lynn Marie Trotti, MD, MSc Pharmacologic therapy is the cornerstone of managing central disorders of hypersomnolence (CDH), but choosing the right treatment can be complex. Join us for an engaging session that explores the full landscape of available medications [...]
14
02, 2026
Sleep Medicine Weekly Insider – February 14, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Attend the AASM Kick Off to SLEEP 2026 Join us for a networking reception at SLEEP 2026 with keynote [...]
3
02, 2026
State of Sleep Medicine Report | 2025, Q4
The State of Sleep Medicine Report is compiled quarterly by the American Academy of Sleep Medicine as a members only resource. The report contains news highlights and announcements to help members identify current trends and innovations in sleep medicine, recognize important developments in [...]
17
01, 2026
Sleep Medicine Weekly Insider – January 17, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Forbes: "Holy grail" sleep apnea pill Apnimed is preparing to file for FDA approval of a nightly pill [...]
10
01, 2026
Sleep Medicine Weekly Insider – January 10, 2026
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. FDA eases health care wearable oversight The FDA updated its guidance on Tuesday to allow more wearables, such as [...]
20
12, 2025
Sleep Medicine Weekly Insider – December 20, 2025
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. AASM seeks clinical guideline volunteers AASM is accepting applications for an update to a guideline task force with [...]
18
12, 2025
A year of momentum for sleep medicine: 2025 recap
The field of sleep medicine continued to evolve in 2025, marked by diagnostic innovation, advancements in novel therapies and a shifting industry landscape. It was also a notable year for the AASM, with several milestones and new resources introduced to support clinicians and [...]
11
12, 2025
AASM joins coalition to protect patient access to telemedicine
The American Academy of Sleep Medicine has signed onto a national coalition letter urging the Office of Management and Budget and the Drug Enforcement Administration to act immediately to prevent a lapse in federal telemedicine flexibilities that millions of patients rely on to [...]
6
12, 2025
Sleep Medicine Weekly Insider – December 6, 2025
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. General registration is open for SLEEP Register for SLEEP 2026, the 40th annual meeting of the Associated Professional [...]